71135

Rosetta-gami B Competent Cells - Novagen

Escherichia coli, rod shaped

• Código UNSPSC: 41106202
• NACRES: NA.81

Propiedades

• Nombre del producto: Rosetta-gami B Competent Cells - Novagen, Rosetta-gami B strains combine the key features of BL21, Origami, and Rosetta to enhance both the expression of eukaryotic proteins and the formation of target protein disulfide bonds.
• origen biológico: Escherichia coli
• Nivel de calidad: 100
• fabricante / nombre comercial: Novagen^®
• condiciones de almacenamiento: OK to freeze; avoid repeated freeze/thaw cycles
• modo de crecimiento: adherent or suspension
• morfología: rod shaped
• técnicas: microbiological culture: suitable
• Condiciones de envío: dry ice
• temp. de almacenamiento: −70°C

Descripción

Descripción general

Genotype: F^–ompT hsdS_B (r_B^– m_B^–) gal dcm lacY1 ahpC gor522::Tn10 trxB pRARE (Cam^R, Kan^R, Tet^R)

This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges us to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.

Rosetta-gami B strains combine the key features of BL21 (and its Tuner derivative), Origami, and Rosetta to enhance both the expression of eukaryotic proteins and the formation of target protein disulfide bonds in the bacterial cytoplasm. These strains are compatible with ampicillin- or spectinomycin-resistant vectors.

Rosetta-gami B strains combine the key features of BL21, Origami, and Rosetta to enhance both the expression of eukaryotic proteins and the formation of target protein disulfide bonds.

Componentes

0.4 ml1 mlComponent

•2 × 0.2 ml5 × 0.2 mlRosetta-gami B Competent Cells

•2 × 2 ml4 × 2 mlSOC Medium

•10 µl10 µlTest Plasmid

Advertencia

Toxicity: Multiple Toxicity Values, refer to MSDS (O)

Información legal

NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany